Histologic grading and prognostic biomarkers in salivary gland carcinomas

Advances in Anatomic Pathology

Volumn 18, Issue 1, 2011, Pages 29-45

  Seethala, Raja R ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

biomarker prognosis; Grade; salivary gland carcinoma

Indexed keywords

ADENOID CYSTIC CARCINOMA; ANAPLASTIC CARCINOMA; CANCER GRADING; CANCER RECURRENCE; CHROMOSOME 1P; CHROMOSOME 6Q; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; MITOSIS; MUCOEPIDERMOID TUMOR; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVARY GLAND CARCINOMA; TUMOR NECROSIS;

ADENOMA, PLEOMORPHIC; CARCINOMA, ACINAR CELL; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; HUMANS; KI-67 ANTIGEN; ONCOGENE PROTEINS, FUSION; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650796874     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e318202645a     Document Type: Review

References (80)

1. Bell RB, Dierks EJ, Homer L, et al. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63:917-928.
2. Eveson JW, Auclair PL, Gnepp DR, et al. Tumors of the salivary glands: Introduction. In: Barnes EL, Eveson JW, Reichart P, et al. eds. World Health Organization Classification of Tumours: Pathology & Genetics. Head and Neck Tumours. Lyon: IARC Press; 2005:221-222.
3. Myers EN, Ferris RL, eds. Salivary Gland Disorders. Berlin: Springer; 2007:422-431.
4. Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3:69-77.
5. el-Naggar AK, Huvos AG. Adenoid cystic carcinoma. In: Barnes EL, Eveson JW, Reichart P, et al. eds. World Health Organization Classification of Tumours: Pathology & Genetics. Head and Neck Tumours. Lyon: IARC Press; 2005:221-222.
6. Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133:702-708.
7. Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: Independent prognostic factors for locoregional control, distant metastases, and overall survival: Results of the Dutch head and neck oncology cooperative group. Head Neck. 2004;26:681-692; discussion 692-693.
8. Lewis JE, Olsen KD, Weiland LH. Acinic cell carcinoma. Clinicopathologic review. Cancer. 1991;67:172-179.
9. Michal M, Skalova A, Simpson RH, et al. Well-differentiated acinic cell carcinoma of salivary glands associated with lymphoid stroma. Hum Pathol. 1997;28:595-600.
10. Seethala RR, Hoschar AP, Bennett A, et al. Reproducibility of grading in salivary gland mucoepidermoid carcinoma and correlation with outcome: Does system really matter? Mod Pathol. 2008;21(S1):241A.
11. Stewart FW, Foote FW, Becker WF. Mucoepidermoid tumors of salivary glands. Ann Surg. 1945;122:820-844.
12. Ellis G, Auclair P, eds. Atlas of Tumor Pathology: Tumors of the Salivary Glands. 3rd Series ed. Washington DC: Armed Forces Institute of Pathology; 1996:17.
13. Aro K, Leivo I, Makitie AA. Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: A single institution's 30-year experience. Laryngoscope. 2008;118:258-262.
14. Nance MA, Seethala RR, Wang Y, et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer. 2008;113:2082-2089.
15. Foote FW Jr, Frazell EL. Tumors of the major salivary glands. Cancer. 1953;6:1065-1133.
16. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: Clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82:1217-1224.
17. Brandwein MS, Ferlito A, Bradley PJ, et al. Diagnosis and classification of salivary neoplasms: Pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol. 2002;122: 758-764.
18. Batsakis JG, Luna MA. Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol. 1990;99(10 Pt 1):835-838.
19. Seethala RR, Dacic S, Cieply K, et al. A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010;34:1106-1121.
20. Weinreb I, Seethala RR, Perez-Ordonez B, et al. Oncocytic mucoepidermoid carcinoma: Clinicopathologic description in a series of 12 cases. Am J Surg Pathol. 2009;33:409-416.
21. Damiani JM, Damiani KK, Hauck K, et al. Mucoepidermoidadenosquamous carcinoma of the larynx and hypopharynx: A report of 21 cases and a review of the literature. Otolaryngol Head Neck Surg. 1981;89:235-243.
22. Keelawat S, Liu CZ, Roehm PC, et al. Adenosquamous carcinoma of the upper aerodigestive tract: A clinicopathologic study of 12 cases and review of the literature. Am J Otolaryngol. 2002;23:160-168.
23. Alos L, Castillo M, Nadal A, et al. Adenosquamous carcinoma of the head and neck: Criteria for diagnosis in a study of 12 cases. Histopathology. 2004;44:570-579.
24. Skalova A, Lehtonen H, von Boguslawsky K, et al. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: Clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol. 1994;25:929-935. (Pubitemid 24292411)
25. Miyabe S, Okabe M, Nagatsuka H, et al. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: A molecular and clinicopathologic study of 101 cases. J Oral Maxillofac Surg. 2009;67:1432-1441.
26. Van Heerden WF, Raubenheimer EJ, Dreyer L. The role of DNA ploidy and Ki-67 in the grading of mucoepidermoid carcinomas. Anticancer Res. 2005;25(3c):2589-2592.
27. Hoyek-Gebeily J, Nehme E, Aftimos G, et al. Prognostic significance of EGFR, p53 and E-cadherin in mucoepidermoid cancer of the salivary glands: A retrospective case series. J Med Liban. 2007;55:83-88.
28. Pires FR, de Almeida OP, de Araujo VC, et al. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:174-180.
29. Kiyoshima T, Shima K, Kobayashi I, et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol. 2001;37: 315-322.
30. Mutoh H, Nagata H, Ohno K, et al. Analysis of the p53 gene in parotid gland cancers: A relatively high frequency of mutations in low-grade mucoepidermoid carcinomas. Int J Oncol. 2001;18:781-786.
31. Nguyen LH, Black MJ, Hier M, et al. HER2/neu and Ki-67 as prognostic indicators in mucoepidermoid carcinoma of salivary glands. J Otolaryngol. 2003;32:328-331.
32. Lujan B, Hakim S, Moyano S, et al. Activation of the EGFR/ ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. Br J Cancer. 2010;103:510-516.
33. Okabe M, Miyabe S, Nagatsuka H, et al. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res. 2006;12:3902-3907.
34. Behboudi A, Enlund F, Winnes M, et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer. 2006;45:470-481.
35. Tirado Y, Williams MD, Hanna EY, et al. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior. Genes Chromosomes Cancer. 2007;46:708-715.
36. Anzick SL, Chen WD, Park Y, et al. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer. 2010;49:59-69.
37. Nakayama T, Miyabe S, Okabe M, et al. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol. 2009;22:1575-1581.
38. Robin C, Laboulbene A. Memoire sur trois productions morbides non decrites. Compte Rend Soc Biol. 1853;5:185-196.
39. Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg. 1992;164:623-628.
40. Fordice J, Kershaw C, El-Naggar A, et al. Adenoid cystic carcinoma of the head and neck: Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999;125:149-152.
41. Perzin KH, Gullane P, Clairmont AC. Adenoid cystic carcinomas arising in salivary glands: A correlation of histologic features and clinical course. Cancer. 1978;42:265-282.
42. Szanto PA, Luna MA, Tortoledo ME, et al. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54:1062-1069.
43. Patey DH, Thackray AC. The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br J Surg. 1958;45:477-487.
44. da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, et al. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol. 2006;42:139-146.
45. Prokopakis EP, Snyderman CH, Hanna EY, et al. Risk factors for local recurrence of adenoid cystic carcinoma: The role of postoperative radiation therapy. Am J Otolaryngol. 1999;20: 281-286.
46. Therkildsen MH, Reibel J, Schiodt T. Observer variability in histological malignancy grading of adenoid cystic carcinomas. APMIS. 1997;105:559-565.
47. Yamamoto Y, Wistuba II, Kishimoto Y, et al. DNA analysis at p53 locus in adenoid cystic carcinoma: Comparison of molecular study and p53 immunostaining. Pathol Int. 1998;48: 273-280.
48. Jia L, Esguerra RL, Tang X, et al. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma. Pathol Int. 2004;54:217-223.
49. Greer RO Jr, Said S, Shroyer KR, et al. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol. 2007;43:735-741.
50. Moskaluk CA, Frierson HF Jr, El-Naggar AK, et al. C-kit gene mutations in adenoid cystic carcinoma are rare. Mod Pathol. 2010;23:905-906; author reply 906-907.
51. Toida M, Balazs M, Mori T, et al. Analysis of genetic alterations in salivary gland tumors by comparative genomic hybridization. Cancer Genet Cytogenet. 2001;127:34-37.
52. El-Rifai W, Rutherford S, Knuutila S, et al. Novel DNA copy number losses in chromosome 12q12-q13 in adenoid cystic carcinoma. Neoplasia. 2001;3:173-178.
53. Freier K, Flechtenmacher C, Walch A, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet. 2005;159: 89-95.
54. Kasamatsu A, Endo Y, Uzawa K, et al. Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses. Int J Biochem Cell Biol. 2005;37:1869-1880.
55. Sandros J, Stenman G, Mark J. Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet. 1990;44:153-167.
56. Lopez-Gines C, Cerda-Nicolas M, Llombart-Bosch A. Cytogenetic findings in a new case of adenoid cystic carcinoma arising in sphenoidal sinus. Cancer Genet Cytogenet. 1994;75: 150-152.
57. Roijer E, Dahlenfors R, Mark J, et al. Observations by chromosome banding, FISH and immunohistochemistry in an adenoid cystic carcinoma with del(17)(p13) as the sole deviation. Virchows Arch. 1997;430:339-342.
58. Vekony H, Ylstra B, Wilting SM, et al. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res. 2007;13: 3133-3139.
59. Bernheim A, Toujani S, Saulnier P, et al. High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Invest. 2008;88:464-473.
60. Rao PH, Roberts D, Zhao YJ, et al. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res. 2008;14:5181-5187.
61. Mitani Y, Li J, Rao PH, et al. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability and clinicopathological significance. Clin Cancer Res. 2010;16:4722-4731.
62. Seethala RR, Hunt JL, Baloch ZW, et al. Adenoid cystic carcinoma with high-grade transformation: A report of 11 cases and a review of the literature. Am J Surg Pathol. 2007;31: 1683-1694.
63. Nagao T, Gaffey TA, Serizawa H, et al. Dedifferentiated adenoid cystic carcinoma: A clinicopathologic study of 6 cases. Mod Pathol. 2003;16:1265-1272.
64. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases. Hum Pathol. 2001;32:596-604.
65. Katabi N, Gomez D, Klimstra DS, et al. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: A clinicopathologic study of 43 cases. Hum Pathol. 2010;41: 927-934.
66. Brandwein M, Huvos AG, Dardick I, et al. Noninvasive and minimally invasive carcinoma ex mixed tumor: A clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:655-664.
67. Muller S, Vigneswaran N, Gansler T, et al. c-erbB-2 oncoprotein expression and amplification in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: Relationship to prognosis. Mod Pathol. 1994;7:628-632.
68. Katori H, Nozawa A, Tsukuda M. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma. Acta Otolaryngol. 2007;127:1207-1213.
69. Nasse D. Die geschwulste der speicheldrusen and verwandte tumoren des kopfes. Arch Klin Chir. 1892;44:233.
70. Buxton RW, Maxwell JH, French AJ. Surgical treatment of epithelial tumors of the parotid gland. Surg Gynecol Obstet. 1953;53:4447-4480.
71. Hoffman HT, Karnell LH, Robinson RA, et al. National Cancer Data Base report on cancer of the head and neck: Acinic cell carcinoma. Head Neck. 1999;21:297-309.
72. Ellis GL, Corio RL. Acinic cell adenocarcinoma. A clinicopathologic analysis of 294 cases. Cancer. 1983;52:542-549.
73. Gomez DR, Katabi N, Zhung J, et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer. 2009;115:2128-2137.
74. Batsakis JG, Luna MA, el-Naggar AK. Histopathologic grading of salivary gland neoplasms: II. Acinic cell carcinomas. Ann Otol Rhinol Laryngol. 1990;99:929-933.
75. Skalova A, Leivo I, Von Boguslawsky K, et al. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections. J Pathol. 1994;173:13-21. (Pubitemid 24182256)
76. Triantafillidou K, Iordanidis F, Psomaderis K, et al. Acinic cell carcinoma of minor salivary glands: A clinical and immunohistochemical study. J Oral Maxillofac Surg. 2010;68:2489-2496.
77. Tanahashi C, Yabuki S, Akamine N, et al. Pure acinic cell carcinoma of the breast in an 80-year-old Japanese woman. Pathol Int. 2007;57:43-46.
78. Piana S, Cavazza A, Pedroni C, et al. Dedifferentiated acinic cell carcinoma of the parotid gland with myoepithelial features. Arch Pathol Lab Med. 2002;126:1104-1105.
79. Henley JD, Geary WA, Jackson CL, et al. Dedifferentiated acinic cell carcinoma of the parotid gland: A distinct rarely described entity. Hum Pathol. 1997;28:869-873.
80. Skalova A, Sima R, Vanecek T, et al. Acinic cell carcinoma with high-grade transformation: A report of 9 cases with immunohistochemical study and analysis of TP53 and HER- 2/neu genes. Am J Surg Pathol. 2009;33:1137-1145.